Prof Tan Sze Wee, is currently the Executive Director of A*STAR’s Science and Engineering Council (SERC).
Prof Tan’s career in A*STAR began in 2009, where he held the appointment of Programme Director of the Medical Technology initiative in SERC. His next appointment was as Director of SERC’s Strategic Initiatives, where he oversaw all SERC cluster-led R&D development. He also provided leadership for SERC’s cross-cutting programmes such as the Thematic Research Programme and the Joint Laboratories programme with the local universities and concurrently spearheaded the Healthcare and Lifestyle (H&L) Programme in A*STAR.
In October 2012, Prof Tan was promoted to Deputy Executive Director in the Biomedical Research Council (BMRC). His experience with the SERC RIs enabled BMRC to engage companies in these industry sectors holistically, cross-promoting the multi-disciplinary capabilities available at both Councils to meet the needs of companies. He helped to pave the way for growth of A*STAR’s engagements with companies in the Food & Nutrition, Medical Technology and Consumer Care sectors with leading MNCs like GE Healthcare, Nestle, Coca Cola and P&G.
Prof Tan is Adjunct Professor at Nanyang Technological University’s School of Chemical and Biomedical Engineering and Lee Kong Chian School of Medicine, as well as an Adjunct Associate Professor at Duke-NUS Graduate Medical School Singapore. He is also Chairman of the Singapore Stanford Biodesign Steering Committee, and member of the steering committee of Rehabilitation Research Institute of Singapore.
Prof Tan was formerly the Managing Director and Chief Executive Officer of Rockeby Biomed Limited. Prior to joining Rockeby, he was the Asia-Pacific Associate Regional Medical Director (Asia Regional Office) for Mead Johnson Nutritionals, a division of Bristol-Myers Squibb Company from 1997 to 2001.
Prof Tan was a former Nominated Member of Parliament of Singapore.
Prof James GOH obtained his BSc (1st Class Honours) in Mechanical Engineering (1978) and PhD in Bioengineering in 1982 from the University of Strathclyde, Glasgow, UK. He is currently Professor and Head, Department of Biomedical Engineering, Faculty of Engineering, NUS and holds a joint appointment, as the Research Professor in the Department of Orthopaedic Surgery, Yong Loo Lin School of Medicine, NUS. He is also Director, Centre for Healthcare Innovation and Medical Engineering (CHIME). Prof Goh is on a number of national as well as international committees. He chairs the Science, Technology and Innovation Advisory Board of the Singapore Sports Institute. He is the President of the Biomedical Engineering Society (Singapore) and the President of the International Federation of Medical and Biological Engineering. Prof Goh has been actively involved in organizing international conferences and had served on numerous International Scientific Committees. He chaired the 6th World Congress of Biomechanics, (2010), TERMIS-AP (2011) and 15th ICBME (2013). Prof Goh has an active research interest in musculoskeletal research and advances in biomedical engineering. He has given numerous invited talks at international and regional conferences. He has published well over 130 international peer review journal papers, more than 500 conference papers and 12 book chapters.
Dr Nilanjan Sen, Ph.D., C.F.A. is Associate Dean (Graduate studies) and Associate Professor of Banking and Finance at Nanyang Business School, NTU. Dr. Sen also concurrently holds an adjunct Associate Professor position at Lorange Institute, Zurich. Professor Sen received his Ph.D. from Virginia Tech and was a faculty member at Arizona State University prior to joining NTU, Singapore.
He has published extensively in academic as well as practitioner journals and currently teaches corporate and international finance. He has presented in several international conferences and presently works in the area of corporate governance and international dividend policy.
In his 8 year at Nanyang Business School, Dr. Sen has provided leadership in several key initiatives. He was Associate Dean of Executive Programs over the period 2008-2014. He launched an innovative EMBA program in 2007 that includes several industry tracks and attracts funding from multiple professional bodies and government agencies. The Nanyang EMBA is currently ranked number 8 in 2014 Financial Times ranking for top 100 programs. He has worked with several leading U.S. universities to launch various Advanced Management Programs that addresses industry specific needs. He has substantially expanded the open and custom program portfolio that includes specialized program for banks and MNCs in one of the highest growing region. He is currently in the process of developing innovative tripartite model in business education that deploy customized curriculum and diversified funding to include private sector businesses, the primary beneficiary of business and network ready graduates. The model seeks to build partnership with key academic institutions and expand the eco system that can jointly serve the expanding global talent development needs.
Dr. Sen has conducted training programs for several corporations, banks and government agencies, was the chief examiner for Certified Investment and Security Analyst Institute (CISA), Thailand, and has worked with several U.S. based preparatory programs for CFA examinations. He currently conducts executive training programs for Cornell-NTU Institute, Nanyang Executive Education as well as CFA review programs for the Financial Training Company. Dr. Sen is also the Academic Director of Nanyang Executive MBA as well as Director, Berkeley-Nanyang Advanced Management Program. In 2004, Professor Sen received the researcher of the year award from School of Global Management and Leadership, Arizona State University and best teacher award from the division of Banking and Finance, Nanyang Business School. He is also the recipient of the Teacher of the Year award in Financial Engineering program for 2006 and 2008. Dr. Sen enjoys squash, hiking, traveling and meeting people from diverse cultures.
Dr Leo Hwa Liang is an Associate Professor with the Department of Biomedical Engineering at the National University of Singapore. A/P Leo’s research focus is the integration of biofluid mechanics with the development of medical devices. One of the several applications centers on the development of implantable devices to be used in areas of cardiovascular circulation and interventional cardiology. His research interests also include the fluid mechanical assessment of cardiovascular devices and therapeutics interventions, and the study of the hemodynamics origin of various cardiovascular diseases. At present, his lab is designing and developing novel heart valve prostheses and vascular stents for percutaneous implantation. A/P Leo’s other research interests and expertise center on the design and development of bioreactors and novel in vitro system for drug screening and toxicological testing. These works involve the use of computational fluid dynamics simulations and experimental setups for the characterization and optimization of the cell culturing systems. A/P Leo graduated with a Bachelor Degree in Mechanical Engineering from the Leeds University in 1996. He obtained his Meng in Mechanical from Thermal and Fluid Division at the Nanyang Technological University in 1999 and his PhD in Mechanical (Bioengineering) from Georgia Institute of Technology, Atlanta in 2005.